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ABSTRACT	
CAENORHABDITIS	ELEGANS	MODEL	TO	STUDY	ANTIMICROBIAL	TREATMENT	
ON	E.	COLI	O157:H7	MAY	2018		PARITA	R	PATEL,	B.S.,	WESTERN	MICHIGAN	UNIVERSITY		M.S.,	UNIVERSITY	OF	MASSACHUSETTS	AMHERST		 Directed	by:	Professor	Lynne	A.	McLandsborough		An	increase	in	antimicrobial	resistance	bacteria	has	endangered	our	ability	to	treat	infectious	diseases.	Lack	of	good	in-vivo	model	has	made	it	difficult	to	study	antimicrobial	resistance.	In	this	study,	we	have	used	an	inexpensive	and	short	life	span	in-vivo	model	namely,	Caenorhabditis	elegans	(C.	elegans)	to	study	antimicrobial	treatment	using	pathogenic	Escherichia	coli	O157:H7,	a	multidrug	resistance	bacterium	that	causes	life	threatening	infection	in	humans.		We	have	investigated	the	influence	of	live	vs.	heat	killed	non-pathogenic	E.	
coli	OP50	(OP50)	as	a	food	source	on	the	growth	and	survival	of	infected	C.	elegans	mutant	AU37	with	E.	coli	O157:H7	in	the	presence	and	absence	of	antibiotics.	This	is	analyzed	using	a	liquid-based	C.	elegans-E.	coli	O157:H7	infection	assay.	C.	elegans	was	synchronized	and	grown	on	a	lawn	of	live	OP50	till	they	reached	L4-young	adult	stage.	L4-young	adults	were	transferred	to	liquid	medium	where	the	C.	elegans	was	infected	with	live	E.	coli	O157:H7	or	live	non-pathogenic	OP50	for	24	hours.	After	infection,	C.	elegans	were	fed	live	or	heat	killed	OP50	depending	on	the	
vii 
experiment,	and	the	life	span	and	levels	of	E.	coli	O157:H7	were	monitored,	with	and	without	ampicillin	treatment	in	a	96	well	transwell	plate.		Our	results	indicate	that	live	OP50	is	an	ideal	food	source	for	C.	elegans	growth	and	survival	to	study	antimicrobial	treatment.	C.	elegans	growth	rate	and	survival	decreased	in	presence	of	heat	killed	OP50,	which	makes	heat	killed	OP50	as	a	non-ideal	food	source	for	antimicrobial	assay.	Moreover,	using	live	OP50	we	have	discovered	that	the	ampicillin	dose	8µg/ml,	16µg/ml,	and	32µg/ml	are	effective	in	increasing	the	survival	of	C.	elegans	infected	with	E.	coli	O157:H7.	However,	treatment	on	C.	elegans	infected	with	acid	stressed	E.	coli	O157:H7	is	controversial.		
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CHAPTER	1	
INTRODUCTION		 Enterohemorrhagic	E.	coli	(EHEC)	is	one	of	the	groups	of	pathogenic	E.	coli,	capable	of	causing	hemorrhagic	colitis	(bloody	diarrhea)	and	hemolytic	uremic	syndrome	(HUS)	(acute	kidney	failure)	in	humans	(Lim	et	al.,	2010).	EHEC	is	also	referred	to	as	Shiga-toxin	producing	E.	coli	(STEC)	because	of	its	ability	to	produce	Shiga-toxins.	E.	coli	O157:H7	is	one	of	the	serotypes	of	EHEC,	recognized	as	the	leading	cause	of	EHEC	outbreaks	in	the	United	States	(Ho	et	al.,	2013).	Treatment	with	E.	coli	O157:H7	is	self-limiting,	as	clinical	studies	indicate	controversial	results	on	the	use	of	antibiotics	to	increase	the	risk	of	development	of	HUS	(Panos	et	al.,	2006).	Lack	of	good	in-vivo	model	has	limited	the	study	of	EHEC	infection	and	treatment.	In	this	study,	we	have	used	an	in-expensive	in-vivo	model	namely	
Caenorhabditis	Elegans	(C.	elegans)	to	study	E.	coli	O157:H7	infection	and	treatment.		Lately,	C.	elegans	has	gained	popularity	to	study	bacterial	pathogenicity	because	of	the	simplicity	of	the	model.	C.	elegans	is	inexpensive,	small	in	size	(»1mm),	have	short	life-span	of	approximately	3	weeks,	and	can	produce	a	large	number	of	offspring	in	short	time	(Corsi	et	al.,	2015).	In	addition,	it	has	65%	of	the	genes	that	are	related	to	human	diseases	and	has	its	entire	genome	sequenced	(Shen	et	al.,	2017).	All	these	characteristics	of	C.	elegans	make	them	an	excellent	model	to	study	bacterial	pathogenicity.		
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The	main	goal	of	this	research	is	to	develop	a	C.	elegans	infection-treatment	model	to	evaluate	the	sensitivity	of	E.	coli	cells	to	the	ampicillin	treatment	in	in-vivo	model.	If	we	will	be	successful	in	developing	the	C.	elegans	infection	system,	we	can	use	the	system	to	study	acid	stressed	E.	coli	O157:H7	infection	using	C.	elegans	model,	which	is	to	be	likely	associated	with	EHEC	infection	as	the	cells	needs	to	pass	through	our	stomach	acid	to	colonize	our	gut.	In	addition,	we	can	use	different	antimicrobials	to	study	antimicrobial	resistance	in	E.	coli	O157:H7,	as	well	as	in	other	food-borne	pathogens.			 	
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CHAPTER	2		
LITERATURE	REVIEW		
2.1	Enterohemorrhagic	Escherichia	coli	O157:H7	
Escherichia	coli	(E.	coli)	is	a	facultative	anaerobic	gram-negative	rod-shaped	bacterium.	Most	E.	coli	strains	are	harmless	and	are	present	as	a	normal	flora	in	the	gastrointestinal	tract	of	humans	and	animals	(Lim	et	al.,	2010).	However,	some	E.	
coli	strains	have	evolved	into	pathogens,	and	are	capable	of	causing	severe	illness	to	humans.		Pathogenic	E.	coli	has	been	divided	into	various	groups	based	on	serogroup,	pathogenicity	mechanisms,	clinical	symptoms,	and/	or	virulence	factors	(Lim	et	al.,	2010).	There	are	six	groups	characterized	as	pathogenic	E.	coli:	Enterohemorrhagic	
E.	coli	(EHEC)	also	referred	to	as	Shiga	toxin-producing	E.	coli	(STEC),	Enterotoxigenic	E.	coli	(ETEC),	Enteropathogenic	E.	coli	(EPEC),	Enteroaggregative	
E.	coli	(EAEC),	Enteroinvasive	E.	coli	(EIEC),	and	Diffusely	Adherent	E.	coli	(DAEC)	(CDC,	2014).	Among	this	groups,	Enterohemorrhagic	Escherichia	coli	(EHEC)	is	most	commonly	associated	with	the	foodborne	outbreaks	(CDC,	2014).	EHEC	have	many	serotypes	O26,	O45,	O91,	O103,	O111,	O121,	O145,	and	O157	(Barlow	and	Mellor,	2010).	Escherichia	coli	serotype	O157:H7	is	the	most	common	cause	of	EHEC	outbreaks	in	the	United	States	(Ho	et	al.,	2013).	EHEC	is	estimated	to	cause	about	265,000	illnesses	in	the	United	States,	among	which	E.	coli	O157:H7	accounts	for	about	36%	of	the	illnesses	(CDC,	2014).		
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One	of	the	major	pathogenic	factors	of	E.	coli	O157:H7	is	the	ability	to	produce	Shiga	toxin	(Tarr	et	al.,	2005).	However,	term	EHEC	is	specifically	referred	to	the	serotype	that	produce	Shiga	toxins,	and	cause	hemorrhagic	colitis	(HC)	and	hemolytic	uremic	syndrome	(HUS)	in	humans	(Lim	et	al.,	2010).	HUS	is	the	leading	cause	of	acute	renal	failure	in	children	(Hu	et	al.,	2013).		
E.	coli	O157:H7	can	grow	at	a	temperature	as	low	as	7°C	and	as	high	as	50°C,	with	an	optimum	growth	temperature	at	37°C	(WHO,	2018).	It	can	grow	in	an	acidic	condition	at	pH	as	low	as	4.4	(WHO,	2018).	E.	coli	O157:H7	activates	regulatory	factor	RpoS	which	helps	the	bacteria	survive	in	acidic	stress	condition	(Jordan	et	al.,	1999).	In	addition,	arginine	and	glutamate-dependent	system	are	also	known	to	play	an	important	role	in	the	survival	of	E.	coli	O157:H7	in	acidic	foods	(Jordan	et	al.,	1999).	EHEC	can	be	destroyed	through	thorough	cooking,	as	it	doesn’t	survive	at	a	temperature	higher	than	70°C	(WHO,	2018).	Young	children,	elderly,	and	immunocompromised	individuals	are	more	susceptible	to	EHEC	infection	(WHO,	2018).	While	some	individuals	have	asymmetric	infections,	others	can	develop	severe	infections	associated	with	bloody	diarrhea	and	abdominal	cramps	within	three	days	of	consuming	contaminated	food	(Hu	et	al.,	2013).	Symptoms	last	an	average	of	3-4	days,	with	a	maximum	duration	of	10	days	(CDC,	2014).		
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2.1.1	E.	coli	O157:H7	History	
E.	coli	O157:H7	was	first	recognized	as	a	human	disease	in	1982,	during	undercooked	hamburger	outbreak,	where	E.	coli	O157:H7	was	known	as	causing	hemorrhagic	colitis	(bloody	diarrhea),	non-bloody	diarrhea,	and	HUS	(Kaper	et	al.,	2004).	However,	it	has	gained	public	attention	in	the	United	States	after	Jack-in-the-Box	outbreak	in	1993,	which	has	resulted	in	more	than	700	illnesses	and	4	deaths	(Armstrong	et	al.,	1996).	Since	then,	many	outbreaks	associated	with	EHEC	infection	has	been	reported.	Table	1	shows	E.	coli	O157:H7	outbreaks	in	the	United	States	since	last	five	years	from	2013-2017	(CDC,	2018).		
Table	1	E.	coli	O157:H7	outbreaks	associated	with	food	from	2013-2017	(CDC,	2018).	Outbreaks	(Year)	 Food	associated	with	E.	coli	O157:H7	outbreak	 Number	of	people	infected	2017	 Romaine	Lettuce	 25	
SoyNut	Butter	 32	
2016	 Beef	Products	 11	
Sprouts	 11	
2015	 Chicken	Salad	 19	
2014	 Ground	Beef	 12	
2013	 Ready	to	eat	Salad	 33	
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2.1.2	Transmission	of	E.	coli	O157:H7	to	humans	
E.	coli	O157:H7	is	a	human	pathogen,	however,	it	is	present	as	a	normal	flora	in	the	intestinal	tract	of	ruminants	such	as	cattle,	sheep,	goat,	and	deer	(Hu	et	al.,	2013).	Human	exposure	to	E.	coli	O157:H7	is	associated	with	ingestion	of	contaminated	food	such	as	undercooked	ground	beef	and	raw	milk	(WHO,	2018).	In	addition,	E.	coli	O157:H7	is	transmitted	to	humans	through	fecal	contamination	of	water	and	food	such	as	fruits	and	vegetables,	cross-contamination	during	food	preparation,	and	even	with	person-person	contact	(Hu	et	al.,	2013;	WHO,	2018).		
	
2.1.3	EHEC	Colonization,	Diagnosis,	and	Treatment	In	humans,	EHEC	infection	develops	when	the	bacteria	colonize	the	gastrointestinal	tract.	The	physical	structure	of	the	E.	coli	O157:H7	contains	fimbriae	which	helps	the	bacteria	adhering	to	the	intestinal	epithelial	cells	(Kaper	et	al.,	2004).	In	humans,	E.	coli	O157:H7	infection	can	be	detected	by	culturing	stool	sample	on	selective/differential	sorbitol-MacConkey	agar	(Tarr	et	al.,	2005).	E.	coli	O157:H7,	unlike	other	non-pathogenic	E.	coli	strains,	cannot	ferment	sorbitol	and	hence	can	appear	colorless/	beige	colonies	on	sorbitol-MacConkey	agar	after	overnight	incubation	at	37°C	(Tarr	et	al.,	2005).		In	vitro	studies	have	shown	antibiotics	to	be	effective	against	E.	coli	O157:H7,	however,	sub-lethal	antibiotic	concentration	can	increase	the	release	of	Shiga	toxins	and	hence	the	development	of	HUS	(Panos	et	al.,	2006).	In	humans,	hydration	is	the	only	recommended	treatment	for	EHEC	infection	(CDC,	2014).	Treatment	with	
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antibiotics	is	controversial	as	some	clinical	studies	indicate	that	antibiotics	treatment	increases	the	risk	of	development	of	HUS	while	some	studies	indicate	antibiotics	as	effective	in	reducing	the	duration	of	the	infection	and	may	prevent	the	development	of	HUS	(Panos	et	al.,	2006).	Here	we	proposed	an	inexpensive	and	simple	in-vivo	model	Caenorhabditis	Elegans	(C.	elegans)	to	study	pathogenicity	and	antimicrobial	treatment.		
	
2.2	Caenorhabditis	Elegans		
Caenorhabditis	Elegans	(C.	elegans)	is	a	small	free-living	transparent	soil	nematode	with	about	1mm	adult	in	length	(Corsi	et	al.,	2015).	Nematodes	can	be	observed	using	a	dissecting	microscope,	which	generally	has	100x	magnification	(Corsi	et	al.,	2015).	It	can	easily	cultivate	in	the	laboratory	with	non-pathogenic	E.	
coli	OP50	as	food	(Riddle	et	al.,	1997).	C.	elegans	can	reproduce	in	2-4	days	depending	on	strain	and	incubation	temperature	(Riddle	et	al.,	1997).	It	has	two	sexes,	male	(rare)	and	a	self-fertilizing	hermaphrodite	which	can	produce	up	to	300	offspring	(Corsi	et	al.,	2015).	Their	lifespan	on	average	is	up	to	2-3	weeks	at	25°C	(Fielenbach	and	Antebi,	2008).	Furthermore,	C.	elegans	has	a	fully	sequenced	genome,	which	makes	them	suitable	for	genetic	studies	(Godballe	et	al.,	2010).	Research	involving	C.	elegans	does	not	need	permission	from	Institutional	Animal	Care	and	Use	Committees	(Shen	et	al.,	2017).	Most	importantly,	C.	elegans	conserve	more	than	65%	of	the	genes	that	are	related	to	human	diseases	(Shen	et	al.,	2017),	which	makes	them	a	suitable	animal	model	to	study	human	bacterial	infection.	
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Figure	1	Anatomy	of	C.	elegans.	(A)	Hermaphrodite	(B)	Male	(Corsi	et	al.,	2015)	(www.wormbook.org)	Licence	by:	https://creativecommons.org/licenses/by/2.5/	
	
2.2.1	Anatomy	and	Life-cycle	of	C.	elegans	The	body	shape	of	C.	elegans	is	unsegmented,	cylindrical	with	an	outer	tube	separated	from	an	inner	tube	(Figure	1)	(Altun	and	Hall,	2009;	Corsi	et	al.,	2015;	Godballe	et	al.,	2010).	The	outer	tube	of	C.	elegans	contains	the	cuticle,	hypodermis,	excretory	system,	neurons,	and	muscles,	where	inner	tube	contains	the	pharynx,	intestine,	and	gonad	in	adult	(Altun	and	Hall,	2009;	Godballe	et	al.,	2010).	The	pharynx	is	one	of	the	important	part	of	the	C.	elegans	as	it	protects	worms	against	bacterial	infection	(Godballe	et	al.,	2010).	The	grinder	in	the	pharynx	grinds	the	bacteria	and	prevent	the	whole	bacteria	from	reaching	to	the	intestine	(Godballe	et	al.,	2010).	Besides	C.	elegans	anatomy,	its	ability	to	sense	different	chemical	signal	as	a	nutrient	or	toxin	helps	them	to	stay	away	from	the	pathogens	and	pathogens	does	not	have	easy	access	to	the	C.	elegans	intestine	(Godballe	et	al.,	2010).		
C.	elegans	has	a	rapid	3-5	days	life-cycle	(from	egg	to	adulthood)	at	temperature	15°C	-	20°C	(Fielenbach	and	Antebi,	2008).	Typical	C.	elegans	life-cycle	
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consists	of	four	larval	stage	from	L1	to	the	L4	stage,	and	then	adulthood	(Figure	2).	It	is	a	good	laboratory	model	to	use	for	life-span	study	because	it	is	easy	to	synchronize	with	the	growth	halt	at	the	L1	stage	in	the	absence	of	food.	When	food	is	available,	worms	can	grow	from	the	L1	to	L4	stage	after	45-50	hours	at	25°C.	L4	stage	worms	can	be	recognized	under	dissecting	microscope	with	its	unique	appearance	having	white	vulva	area.	In	overcrowding	and	lack	of	food	condition,	it	can	go	to	dauer	stage	where	it	can	survive	up	to	4	months	without	food	and	can	again	start	to	feed	and	reaches	to	the	L4	stage.	As	the	dauer	can	survive	for	months,	it	can	be	kept	as	a	stock	in	a	petri	dish	at	15°C	(Corsi	et	al.,	2015).			
	
Figure	2	Life	cycle	of	C.	elegans	(Altun	and	Hall,	2009)	(http://www.wormatlas.org).	
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2.2.2	C.	elegans	as	a	model	for	E.	coli	O157:H7	infection	and	treatment	In	a	laboratory,	C.	elegans	can	easily	grow	on	a	petri	dish	and	fed	on	non-pathogenic	bacterial	strain	E.	coli	OP50.	C.	elegans	can	be	used	to	study	EHEC	infection	simply	by	replacing	its	food	with	pathogenic	bacteria.	However,	it	is	important	to	understand	C.	elegans	behavioral	response	to	bacterial	food	as	C.	
elegans	can	sense	the	difference	between	the	nutrient	and	toxin	(Godballe	et	al.,	2010).		Many	human	bacterial	pathogens	kill	C.	elegans	by	colonizing	their	intestine,	and	the	pathology	is	measured	as	a	decrease	in	the	life-span	of	C.	elegans	(Darby,	2005).	Hence,	C.	elegans	intestinal	bacterial	colonization	can	be	quantified	using	plate	count	method.	E.	coli	OP50	does	not	colonize	the	C.	elegans	intestine	(Darby,	2005).	Bacterial	pathogens	can	kill	C.	elegans	by	releasing	the	toxin	(fast-killing)	or	by	colonizing	the	C.	elegans	intestine	(slow	killing)	(Darby,	2005).		As	C.	elegans	conserve	about	65%	of	the	genes	related	to	the	human	diseases	(Shen	et	al.,	2017),	has	its	full	genome	sequenced	(Godballe	et	al.,	2010),	and	because	of	the	simplicity	of	the	model,	C.	elegans	is	widely	used	in	pathogenicity	and	human	diseases	study.	Previous	research	on	plate-liquid	infection	assay	has	shown	that	enterohemorrhagic	E.	coli	(EHEC),	enteroaggregative	E.		coli	(EAEC),	enteropathogenic	E.	coli	(EPEC),	and	uropathogenic	E.	coli	(UPEC)	is	pathogenic	to	C.	
elegans	(Chou	et	al.,	2013;	Merkx-Jacques	et	al.,	2013).	Here,	we	propose	a	liquid-liquid	infection-treatment	assay	as	a	simple	experimental	procedure	to	study	the	antibiotic	treatment	of	E.	coli	O157:H7.	 	
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CHAPTER	3	
OBJECTIVES	
	1. To	determine	if	heat-killed	E.	coli	OP50	is	a	good	food	source	for	C.	elegans	compared	to	live	E.	coli	OP50	in	infection-treatment	assay.	2. To	determine	if	C.	elegans	is	an	appropriate	model	to	study	E.	coli	O157:H7	infection	and	treatment	in-vivo.		3. To	determine	if	ampicillin	treatment	is	effective	in	worms	infected	with	acid	stressed	E.	coli	O157:H7	cells	compared	to	the	worms	infected	with	non-acid	stressed	E.	coli	O157:H7	cells.	
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CHAPTER	4	
MATERIALS	AND	METHODS	
	
4.1	Bacterial	strains,	media	and	preservation	
	 Bacterial	strain	non-pathogen	E.	coli	OP50	(OP50)	was	used	as	nematode	food	and	was	obtained	from	Dr.	Park	Lab,	University	of	Massachusetts,	Amherst.	Bacterial	strain	pathogen	E.	coli	O157:H7	(laboratory	number	E21B)	was	used	to	infect	worms	and	was	obtained	from	American	Type	Culture	Collection	(ATCC)	(ATCC	43895,	Manassas,	VA).		Concentrated	E.	coli	OP50	used	as	nematodes	food	in	96	Transwell	(Corning	HTS	Transwell	96	well	pore	size	0.4µm,	Sigma-Aldrich,	St.	Louis,	MO)	was	prepared	by	mixing	a	loop	full	of	OP50	culture	from	a	streaked	plate	into	200ml	Luria-Bertani	broth	(Becton,	Dickinson	and	Company,	Franklin	Lakes,	NJ,	USA)	and	incubated	at	37°C	overnight	on	a	125rpm	shaker.	Then,	the	mixture	was	centrifuged	(Sorvall	ST	8	small	benchtop	centrifuge	with	TX-150	swinging	bucket	rotor	(Thermo	Fisher	Scientific	Inc.,	Waltham,	MA)	at	2,500g	for	10	minutes	and	the	supernatant	was	discarded.	OP50	pellet	was	concentrated	to	100	mg/ml	in	a	sterilized	water	(Solis	and	Petrascheck,	2011).	The	culture	was	stored	at	-20°C.	Heat-killed	OP50	was	prepared	by	incubating	concentrated	OP50	in	70°C	hot	bath	for	30	minutes	(Ren	et	al.,	2009).	Frozen	bacterial	stock,	E.	coli	OP50	and	E.	coli	O157:H7,	were	prepared	for	long-term	storage.	Bacterial	culture	was	grown	overnight	in	a	Tryptic	Soy	Broth	(TSB)	(Becton,	Dickinson	and	Company,	Franklin	Lakes,	NJ,	USA).	Sterile	glycerol	
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(50%	glycerol	w/v	in	dH2O)	was	added	at	a	proportion	of	1-part	glycerol:1-part	TSB	containing	bacterial	culture	and	mixed	into	a	small	sterile	tube.	The	mixture	was	stored	at	-80°C.	Tryptic	Soy	Agar	(TSA)	(Becton,	Dickinson	and	Company,	Franklin	Lakes,	NJ,	USA)	plate	was	streaked	from	the	frozen	stock	each	time	for	the	new	experiment.	The	streaked	plates	were	discarded	after	a	week.		
	
4.2	Nematode	strains,	media	and	preservation		 Caenorhabditis	elegans	(C.	elegans)	strain	AU37	was	purchased	from	Caenorhabditis	Genetics	Center	(CGC,	University	of	Minnesota,	Minneapolis,	MN).	Some	strains	were	provided	by	the	CGC,	which	is	funded	by	NIH	Office	of	Research	Infrastructure	Programs	(P40	OD010440).	Strain	AU37	is	a	double	mutant	(glp-4	
(bn2ts);	sek-1(km4)),	where	glp-4	is	a	temperature-sensitive	mutation	that	does	not	allow	proliferation	at	25°C	and	sek-1	is	a	mutation	that	increases	C.	elegans	susceptibility	to	pathogens	(Zhou	et	al.,	2011).	C.	elegans	mutant	AU37	were	maintained	at	15°C.	C.	elegans	strain	N2,	wild-type	strain,	was	obtained	from	Dr.	Park	Lab,	University	of	Massachusetts,	Amherst.		 Nematode	growth	medium	agar	plates	(NGM,	US	Biological	Life	Sciences	Inc.,	Salem,	MA,	prepared	with	1M	Calcium	Chloride,	1M	Dipotassium	Phosphate	(Sigma-Aldrich,	St.	Louis,	MO),	and	1M	Magnesium	Sulfate	(Thermo	Fisher	Scientific	Inc.,	Waltham,	MA))	were	prepared	according	to	the	manufacturer’s	instructions.	E.	coli	OP50	was	grown	at	37°C	in	a	Luria-Bertani	broth	for	12-14	hours	on	a	125rpm	shaker	and	1	ml	of	overnight	culture	was	added	to	the	center	of	NGM	agar	plates.	The	plates	were	incubated	at	room	temperature	for	48	hours,	to	allow	for	growth	
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(considered	as	NGM	seeded	with	OP50).	After	48	hours,	plates	were	sealed	in	a	plastic	bag	to	prevent	contamination	and	moisture	loss	and	moved	to	4°C	incubator.			 Nematode	working	cultures	were	prepared	by	transferring	a	piece	of	an	NGM	agar	containing	C.	elegans	to	a	NGM	plate	seeded	with	OP50	and	incubated	at	15°C	for	4-5	days.	When	the	working	culture	plate	contained	many	L1	stage	worms	(as	determined	by	observation	with	a	dissecting	microscope),	the	plate	was	sealed	with	parafilm	to	prevent	contamination	and	loss	of	moisture	and	stored	at	15°C.	The	plate	was	kept	for	about	two	months	and	then	discarded.	New	working	culture	nematodes	were	prepared	using	the	same	procedure,	from	an	old	NGM	plate	containing	many	worms.		
	
4.3	Synchronization	of	worms	Worms	were	synchronized	following	the	protocol	described	by	Stiernagle,	with	some	modification	(2006)	(wormbook.org).	Synchronized	worms	were	prepared	by	placing	a	section	of	NGM	agar	containing	worms	onto	a	new	NGM	plate	seeded	with	OP50	and	incubated	at	15°C.	When	large	numbers	of	eggs	laid,	eggs	were	collected	by	washing	the	plate	with	sterile	water	and	collecting	the	mixture	into	a	15ml	sterile	centrifuge	tube.	The	tube	containing	worms	and	eggs	were	centrifuged	at	2000g	for	2	minutes	and	the	supernatant	was	discarded.	The	pellet	was	suspended	in	10	ml	bleach	solution	(18%	household	bleach	(The	Clorox	Company,	Oakland,	CA)	and	10%	NaCl	(Thermo	Fisher	Scientific	Inc.,	Waltham,	MA)	in	a	sterile	water)	and	vortexed	for	2-2.5	minutes	at	high	speed	to	destroy	worms,	then	centrifuged	(2000	g,	1	min),	and	supernatant	was	discarded.	Pellet	containing	
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eggs	was	suspended	in	M9	buffer	(5.8g	Na2HPO4,	2g	KH2PO4,	0.5g	NaCl,	and	1g	NH4Cl	(Thermo	Fisher	Scientific	Inc.,	Waltham,	MA)	per	1L	distilled	water	(Ahringer,	2006;	Stiernagle,	2006))	to	neutralize	the	reaction,	centrifuged	(2000g,	2	mins),	and	supernatant	was	discarded.	Pellet	was	re-suspended	into	an	M9	buffer,	centrifuged	(2000g,	2	mins),	and	the	supernatant	was	discarded.	Washed	eggs	were	suspended	into	a	1ml	M9	buffer	and	incubated	at	25°C	to	hatch.	After	24	hours,	hatched	eggs	(now	L1	stage	worms)	were	transferred	onto	NGM	plate	seeded	with	live	OP50.	Worms	were	grown	to	sterile	L4-young	adult	at	25°C	which	was	typically	achieved	after	a	45-50	h	incubation.	Mutant	AU37	does	not	produce	eggs	at	25°C.		
4.4	Determination	of	minimal	inhibitory	concentration		 Minimal	inhibitory	concentration	(MIC)	in-vitro	was	performed	to	determine	the	lowest	concentration	of	ampicillin	that	inhibits	E.	coli	O157:H7	growth,	to	treat	
C.	elegans	infected	with	E.	coli	O157:H7.	The	antimicrobial	effectiveness	of	ampicillin	on	E.	coli	O157:H7	was	measured	using	broth	microdilution	method	described	by	Reimer	et	al.	with	little	modification	(1981).	E.	coli	O157:H7	was	grown	in	a	Mueller-Hinton	Broth	(MHB)	(Becton,	Dickinson	and	Company,	Franklin	Lakes,	NJ,	USA)	overnight	and	then	diluted	1:10	to	measure	the	absorbance	at	625nm.	0.85%	NaCl	was	used	as	a	blank	solution.	The	test	was	performed	in	a	96	well	microtiter	plate	(Corning	Incorporated,	Corning,	NY)	in	which	50µl	MHB	was	added	to	each	well,	and	a	two-fold	serial	dilution	of	ampicillin	was	performed.	Then,	50µl	of	an	overnight	E.	
coli	O157:H7	culture	was	added	to	each	well.	The	final	concentrations	of	ampicillin	
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were	ranging	from	0.25µg/ml	to	64µg/ml.	The	microtiter	plate	was	incubated	at	37°C	for	20-24	hours,	and	the	absorbance	was	measured	at	625nm	using	ELx800	Microtiter	Plate	Reader	(BioTek	Instruments	Inc.,	Winooski,	VT).	Ampicillin	stock	was	prepared	by	filter	sterilizing	512mg/ml	ampicillin	in	a	sterilized	water	using	0.22	µm	filter.	The	stock	was	stored	in	100µl	volume	at	-20°C.		
4.5	Bacterial	colonization		 Worms	intestinal	bacterial	colonization	was	determined	as	described	by	Moy	et	al.	(2006).	Approximately	10	worms	were	collected	in	a	small	centrifuge	tube	and	washed	3	times	with	approximately	250µl	of	1mM	sodium	azide	(Acros	Organics,	Thermo	Fisher	Scientific,	NJ,	USA).	50µl	of	the	supernatant	was	plated	onto	Sorbitol	MacConkey	agar	(OXOID	LTD.,	Basingstoke,	Hampshire,	England)	to	determine	the	external	CFU.	Approximately	400mg	of	1.0mm	silicon	carbide	particles	(BioSpec	Inc.,	Bartlesville,	OK,	USA)	was	added	to	the	tube	and	vortexed	at	high	speed	for	approximately	one	minute	to	disrupt	the	worms.	The	suspension	was	then	diluted	and	plated	onto	Sorbitol	MacConkey	agar.	The	plates	were	incubated	at	37°C	for	20-24	hours	and	the	internal	CFU/	worm	was	determined.			
4.6	E.	coli	O157:H7	growth	curve		
E.	coli	O157:H7	growth	curve	was	performed	to	determine	the	time	required	for	E.	coli	O157:H7	grown	in	Luria-Bertani	broth	with	pH	6.80±0.10	and	pH	5.25±0.05	to	reach	to	the	late-exponential	stage.	Luria-Bertani	broth	pH	was	
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adjusted	using	99.5%	pure	acetic	acid	(Acros	Organics,	Thermo	Fisher	Scientific,	NJ,	USA)	(Deng	et	al.,	1999).	E.	coli	O157:H7	was	grown	on	a	Luria-Bertani	broth	without	pH	adjustment	(pH	6.80±0.10)	for	18-20	hours	at	37°C,	centrifuged	at	2500g	for	10	minutes,	and	the	supernatant	was	discarded.	M9	buffer	was	added	to	make	the	final	E.	coli	O157:H7	concentration	of	105	CFU/ml.	E.	coli	O157:H7	concentration	of	105	CFU/ml	was	then	added	to	the	pH	adjusted	(pH	5.25±0.05)	and	non-pH	adjusted	(pH	6.80±0.10)	Luria-Bertani	broth	to	make	the	final	bacterial	concentration	of	104	CFU/ml.	These	enrichments	were	incubated	at	37°C	and	the	absorbance	was	taken	at	a	wavelength	of	625nm	every	hour	to	plot	an	E.	coli	O157:H7	growth	curve.	
	
4.7	C.	elegans-E.	coli	O157:H7	infection	lifespan	assay		 The	lifespan	assay	was	carried	out	by	synchronizing	the	worms	to	the	L4-young	adult	stage	as	described	in	“synchronization	of	worms”	section.	NGM	plate	containing	L4-young	adult	stage	worms	were	washed	using	an	M9	buffer	and	suspended	into	a	sterile	2ml	microcentrifuge	tube,	centrifuged	(2000g,	2min)	using	accuSpin	Microcentrifuge	with	fixed	angle	rotor	(Fisher	Scientific,	Waltham,	MA),	and	the	supernatant	was	discarded.	The	worms	were	washed	(centrifuged	at	2000g,	2	min)	at	least	three	times	with	M9	buffer.	Approximately	100	AU37	worms	were	added	to	each	well	in	24	well	plate,	containing	109	CFU	of	E.	coli	OP50	(refer	to	as	control)	and	109	CFU	of	E.	coli	O157:H7	(refer	to	as	infected),	each	in	1ml	M9	buffer	(v/v).	For	N2	worms,	120µM	fluorodeoxyuridine	(FUDR)	(Tokyo	Chemical	Industry	
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CO.,	LTD.,	Portland,	OR)	was	added	to	the	final	concentration	of	1ml	to	make	worms	infertile	(Solis	and	Petrascheck,	2011).	The	plate	was	incubated	at	25°C	for	24	hours.	After	24	hours,	both	control	and	infected	worms	were	suspended	into	a	micro-centrifuged	tube	and	washed	at	least	three	times	with	M9	buffer.	Approximately	10	infected	worms	were	suspended	in	a	2ml	micro-centrifuge	tube	to	determine	the	internal	bacterial	colonization	count.	Bacterial	colonization	count	was	determined	as	described	in	section	4.5.		The	treatment	was	performed	in	96	well	trans-well	with	varied	concentration	of	ampicillin	(8µg/ml,	16µg/ml,	and	32µg/ml).	The	control	and	infected	worms	without	ampicillin,	and	with	ampicillin	(8µg/ml,	16µg/ml,	and	32µg/ml)	were	used	to	compare	the	results.	Live	or	heat-killed	OP50	were	used	as	nematodes	food	depending	on	an	experiment.	Each	treatment	was	performed	in	five	duplicates.	The	initial	number	of	worms	in	each	well	were	counted	and	the	plate	was	incubated	at	25°C.	The	number	of	worms	alive	in	each	well	were	counted	every	other	day	till	all	worms	died.	The	food	in	the	wells	was	changed	as	needed.	The	experiment	was	repeated	independently.	Refer	to	Appendix	A	for	detailed	experimental	procedure.		
4.8	Heat	stress	assay		 Heat	stress	assay	was	performed	similarly	as	described	in	section	4.7.,	with	little	modification.	After	treatment,	number	of	worms	alive	were	counted	in	96	well	
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transwell	plate	and	the	plate	were	incubated	at	37°C.	The	number	of	worms	alive	was	counted	every	60	to	90	minutes.			
4.9	Acid	stress	assay		 Acid	stress	assay	was	performed	in	a	similar	manner	as	mentioned	in	section	4.7.,	with	little	modification.	E.	coli	O157:H7	and	E.	coli	OP50	cells	were	grown	overnight	on	Luria-Bertani	medium	(pH	=	5.25	±	0.05).	E.	coli	O157:H7	and	E.	coli	OP50	cells	were	also	grown	in	Luria-Bertani	broth	without	pH	adjustment	(pH	=	6.65	±	0.05),	which	will	refer	to	as	infected	control.	E.	coli	O157:H7	and	E.	coli	OP50	cells	were	grown	to	the	late	exponential	stage,	the	pellet	was	collected,	and	the	supernatant	was	discarded.	The	pellet	was	then	suspended	into	an	M9	buffer	and	the	worms	were	fed	with	106	CFU	E.	coli	O157:H7	and	E.	coli	OP50	concentration	per	1ml	of	M9	buffer	(v/v).		
4.10	Statistical	Analysis		 Statistical	Analysis	was	performed	using	the	Graph	Pad	Prism	version	7.0c	for	Mac	OS	X	(GraphPad	Software,	Inc.).	Log-rank	(Mantel-Cox)	and	Gehan-Breslow-Wilcoxon	test	were	performed	to	analyze	the	significant	difference	in	survival	curves.	P-value	<	0.05	is	considered	as	significantly	different.				 	
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CHAPTER	5	
RESULTS	AND	DISCUSSION		
5.1	C.	elegans	mutant	AU37	is	preferable	in	infection	assay	compared	to	wild	
type	N2	Infection	assays	using	E.	coli	O157:H7	(E21B)	were	performed	with	C.	
elegans	strains	AU37	(mutant)	and	N2	(wild	type).	C.	elegans	strain	AU37	is	a	double	mutant	strain,	with	temperature	sensitivity	and	an	increased	susceptibility	to	pathogens	(Zhou	et	al.,	2011).	Both	C.	elegans	strains,	AU37	and	N2,	were	exposed	to	E21B	or	E.	coli	OP50	(OP50,	non-pathogenic	negative	controls)	for	24	hours	in	an	M9	buffer,	worms	were	recovered,	and	transferred	to	96	well	plate	(T=0),	and	the	worms	were	fed	heat-killed	OP50	during	the	duration	of	the	experiment.	E21B,	an	enterohemorrhagic	E.	coli,	was	expected	to	infect	and	shorten	the	life-span	of	the	worms,	while	non-pathogenic	OP50	was	used	as	a	negative	control	and	was	not	expected	to	shorten	the	life-span.		The	survival	of	C.	elegans	AU37	infected	with	E.	coli	O157:H7	had	a	reduced	life-span	compared	to	the	AU37	infected	with	non-pathogenic	E.	coli	OP50,	however	the	differences	were	not	significant	(P>0.05)	(Figure	3A).	The	survival	of	C.	elegans	N2	infected	with	E21B	was	not	different	compared	to	OP50	(Figure	3B).	The	results	indicated	that	E21B	may	successfully	infect	AU37;	however,	it	may	fail	to	infect	N2.	We	are	not	sure	whether	E21B	can	infect	and	colonize	the	N2	strain	later	in	the	life	of	worms	since	the	assay	was	terminated	for	N2	after	19	days,	when	all	AU37	died.	
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Based	on	the	19	days	life-span	study,	N2	is	not	susceptible	to	E21B	infection.	Chou	et	al.	has	showed	E.	coli	O157:H7	does	colonize	N2	worms	(2013).	However,	in	order	to	shorten	the	experimental	duration,	we	concluded	that	the	AU37	is	more	suitable	for	infection	assay.			
	
			 	
Figure	3	Infection	assay	with	E.	coli	O157:H7.	Worms	were	grown	to	L4/	young	adult	stage	and	transferred	to	24	well	plate	containing	109	CFU/ml	E.	coli	O157:H7	in	M9	buffer	or	similar	levels	of	E.	coli	OP50.	Worms	infected	with	E.	coli	O157:H7	and	E.	coli	OP50	for	24	hours.	Worms	were	recovered	and	transferred	to	a	96	well	trans-well	plate	(T=0)	containing	heat-killed	OP50	as	a	food	source	for	the	remainder	to	the	experiment	at	25°C	and	survival	was	counted	every	day	for	19	days.	Graph	Pad	Prism	Log-rank	(Mantel-Cox)	test	was	used	to	obtain	the	p-value.	(A)	AU37	(p=0.2781)	(B)	N2	(p=0.5954).	P-value	of	less	than	0.05	is	considering	to	be	statistically	different.	 	
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5.2	Heat-killed	OP50	significantly	decreases	the	life-span	of	C.	elegans	strain	
AU37		 We	originally	tested	the	C.	elegans	AU37	infection	assay	using	heat-killed	OP50	as	post-infection	food	in	trans-well	plate.	This	was	done	due	to	the	concern	that	live	non-pathogenic	bacteria	(OP50)	will	interfere	with	live	pathogenic	bacteria	(E21B)	and	will	mislead	the	intestinal	colonization	numbers	in	worms.	In	addition,	the	goal	was	to	develop	an	in-vivo	infection	assay	for	antibiotic	efficiency;	we	were	concerned	that	the	antibiotic	will	also	kill	OP50,	which	may	complicate	the	system.				C.	elegans	AU37	fed	with	heat-killed	OP50	had	a	significantly	shorter	the	life-span	compared	to	the	worms	fed	with	live	OP50	(Figure	4).	When	a	preliminary	study	was	done	with	synchronized	worms	(L1	stage)	fed	with	heat-killed	OP50	vs.	live	OP50	on	NGM	lawn,	we	observed	the	worms	fed	with	live	OP50	has	reached	to	L4/	young	adult	stage	within	48	hours,	whereas	worms	fed	with	heat-killed	OP50	were	significantly	smaller,	and	we	hypothesize	they	may	possibly	move	to	a	dauer	stage	(Figure	5).	This	indicates	that	live	OP50	is	needed	to	provide	sufficient	nutrient	to	the	C.	elegans	AU37	for	its	growth	and	survival.	Live	OP50	were	used	to	feed	C.	elegans	AU37	after	infection	in	all	subsequent	experiments.	
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Figure	4	AU37	survival	assay	fed	with	live	vs.	heat-killed	OP50.	Worms	were	grown	to	L4/	young	adult	stage	and	transferred	to	96	trans-well	plate	where	worms	were	fed	with	live	vs.	heat-killed	OP50.	Survival	was	counted	every	day	till	all	worms	died.	Graph	Pad	Prism	Log-rank	(Mantel-Cox)	(P=0.0032)	and	Gehan-Breslow-Wilcoxon	(P=0.0100)	tests	were	used	to	obtain	a	p-value.	
		 	
Figure	5	Dissecting	microscope	image	of	AU37	after	48	hours.	Worms	were	synchronized	and	transferred	to	the	NGM	plate	containing	lawn	of	live	vs.	heat-killed	OP50	after	24	hours.	Dissecting	microscopic	image	was	taken	using	a	digital	camera	(AmScope	MU1400	with	FMA050	lens,	AmScope,	Irvine,	CA)	after	48	hours.	Image	shown	are	at	highest	magnification.	(A)	AU37	grown	on	a	live	OP50	lawn.	(B)	AU37	grown	on	a	heat-killed	OP50	lawn.	 	
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5.3	Ampicillin	treatment	significantly	increases	the	life-span	of	infected	
worms	In	order	to	determine	whether	C.	elegans	is	an	appropriate	model	to	study	E.	
coli	O157:H7	infection	and	treatment	in-vivo,	we	had	fed	C.	elegans	AU37	with	E.	coli	O157:H7	(we	will	refer	to	these	worms	as	infected)	for	24	hours,	and	transferred	to	a	transwell	plate	with	live	E.	coli	OP50	with	and	without	treatment	with	ampicillin	at	various	concentrations.	The	control	was	C.	elegans	mutant	AU37	infected	with	E.	
coli	OP50	(we	will	refer	to	as	control)	for	24	hours	and	treated	with	ampicillin	in	a	96	transwell	plate.	A	previous	study	has	been	done	testing	EHEC	pathogenicity	on	C.	
elegans	(Chou	et	al.,	2013)	however,	limited	studies	have	been	performed	on	the	effectiveness	of	antibiotics	using	C.	elegans	model.	Hence,	minimum	inhibitory	concentration	test	in-vitro	was	performed	to	determine	the	minimum	ampicillin	concentration	that	inhibits	the	growth	of	E.	coli	O157:H7.	Starting	with	in-vitro	minimum	inhibitory	concentration	(0.25-1µg/ml),	we	determined	the	minimum	effective	ampicillin	concentration	to	treat	E.	coli	O157:H7	infection	in-vivo	was	much	higher	(8µg/ml).		Pathogenicity	of	E.	coli	O157:H7	to	C.	elegans	AU37	was	tested,	and	determined	to	significantly	decrease	in	the	life-span	of	infected	worms	compared	to	the	control	worms	(Figure	6A).	The	result	indicates	that	E.	coli	O157:H7	is	pathogenic	to	the	C.	elegans	strain	AU37.	Treatment	with	ampicillin	was	tested	on	infected	worms	and	determined	that	the	worms	fed	with	ampicillin	concentration	8µg/ml,	16µg/ml,	and	32µg/ml	after	being	infected	for	24	hours	with	an	initial	
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infection	of	2.4	x	102	CFU/worm,	shows	significant	increase	in	the	life-span	of	infected	worms	(Figure	6	(B-D)).	This	indicates	that	ampicillin	concentration	8µg/ml,	16µg/ml,	and	32µg/ml	are	effective	in	treating	E.	coli	O157:H7	infection	in	
C.	elegans	strain	AU37.	Control	worms	were	fed	with	ampicillin	concentration	8µg/ml,	16µg/ml,	and	32µg/ml	in	96	transwell	plate	to	ensure	ampicillin	concentrations	was	toxic	to	the	worms	(results	not	shown).	The	control	results	are	contradictory,	as	ampicillin	did	not	affect	the	life-span	of	the	worms	in	a	first	trial,	whereas	ampicillin	decreases	the	life-span	of	the	worms	compared	to	the	control	in	a	second	trial.	However,	the	treatment	with	ampicillin	on	infected	worms	did	not	appear	as	toxic,	since	the	life-span	of	the	infected	worms	treated	with	ampicillin	survived	significantly	more	than	infected	alone	(Figure	6	(B-D))	and	mimiced	the	survival	of	the	control	worms	(not	shown).	Further	studies	on	the	appearance	of	the	worms	(body	size	and	shape)	and	its	activity	(movement	and	pharyngeal	pumping)	need	to	study	to	enlighten	the	effect	of	ampicillin	on	C.	elegans	strain	AU37.		Intestinal	bacterial	colonization	assay	was	performed	on	infected	and	ampicillin	treated	worms	to	determine	whether	the	ampicillin	treatment	reduced	the	bacterial	colonization	overtime	in	worms	intestine.	Approximately	10	worms	were	used	to	determine	the	intestinal	bacterial	colonization.	Treatment	with	ampicillin	dose	16µg/ml	and	32µg/ml	significantly	decreased	intestinal	bacterial	colonization	in	the	worms	(1.38	log)	compared	to	the	infected	worms	without	ampicillin	treatment	(Figure	6E).	The	results	indicates	that	E21B	has	colonized	and	replicated	in	worms	intestine,	which	supports	the	findings	of		Chou	et	al.	(2013);	
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and	the	treatment	with	ampicillin	decreased	the	intestinal	bacterial	colonization	in	the	worms.	The	experiment	was	performed	twice	(independently)	with	the	significant	result	when	infected	worms	were	treated	with	ampicillin.	These	findings	suggest	C.	elegans	as	an	appropriate	model	to	use	as	an	in-vivo	model	to	study	bacterial	infection	and	its	treatment.	However,	there	was	variability	on	the	life-span	of	the	worms	between	both	trials.	This	could	possibly	be	due	to	the	initial	infection	in	the	worms	intestine	(4.9	x	102	CFU/worm	in	first	trial	compared	to	2.4	x	102	CFU/worm	for	the	results	shown).	In	both	experiments,	worms	were	fed	with	the	same	number	of	bacteria,	however,	the	number	of	bacteria	eaten	by	worms	varies	and	could	then	influence	the	life-span.		 	
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Figure	6	C.	elegans	AU37	infection	with	E.	coli	O157:H7	(E21B)	in	a	liquid	medium	using	ampicillin	treatment.	C.	elegans	were	grown	to	L4/	young	adults	and	transferred	to	24	well	plate	containing	»109	CFU	E.	coli	O157:H7	and	»109	CFU	E.	
coli	OP50	(control)	per	1ml	M9	buffer	(v/v).	Worms	were	fed	with	E21B	and	OP50	for	24	hours	in	an	M9	buffer.	Worms	were	transferred	to	96	transwell	plate	and	fed	with	live	E.	coli	OP50	and	ampicillin	(0µg/ml,	8µg/ml,	16µg/ml,	and	32µg/ml).	GraphPad	Prism	7	was	used	to	obtain	the	p-value	and	T50	(Table	2)	(A)	Life-span	of	control	worms	(OP50)	and	infected	worms	(E21B)	without	ampicillin	treatment.	(B)	Life-span	of	infected	worms	with	8µg/ml	ampicillin	(Amp	8)	and	without	ampicillin	(E21B)	treatment.	(C)	Life-span	of	infected	worms	with	16µg/ml	ampicillin	(Amp	16)	and	without	ampicillin	(E21B)	treatment.	(D)	Life-span	of	infected	worms	with	32µg/ml	ampicillin	(Amp	32)	and	without	ampicillin	(E21B)	treatment.	(E)	Intestinal	colonization	of	infected	worms	at	Day	0	and	worms	with	and	without	ampicillin	treatments	(E21B,	Amp	8,	Amp	16,	Amp	32)	at	Day	24,	the	dotted	line	indicated	minimum	detectable	level	(1	x	101	CFU/worm).	 	
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	Table	2	Statistical	summary	of	C.	elegans	AU37	infection	with	E21B	
GraphPad	Prism	7	for	Mac	OS	was	used	to	obtain	statistical	summary	on	C.	elegans	AU37	infection	with	E21B	in	a	liquid	medium	using	ampicillin	treatment.	The	p-value	confirms	the	life-span	study	(Figure	4	(A-D))	is	significant.	T50	indicates	that	the	worms	treated	with	ampicillin	(8µg/ml	and	16µg/ml)	have	significantly	higher	survival	rate	compared	to	the	worms	without	treatment.	A	p-value	less	than	0.05	is	significant.	T50	defines	as	a	time	taken	when	50%	of	the	worms	died.			 	
Infection	 Ampicillin	Treatment	(µg/ml)	 Median	life-span	T50	(days)	
P-value	compared	to	E21B	without	treatment	Log-rank	(Mantel-Cox)	test	
Gehan-Breslow-Wilcoxon	test	
Significant?	
E.	coli	OP50	 0	 20	 0.0208	 0.0236	 Yes	
E.	coli	E21B		 0	 18	 NA	 NA	 NA	
E.	coli	E21B		 8	 22	 0.0047	 0.0075	 Yes	
E.	coli	E21B		 16	 22	 0.0002	 <0.0001	 Yes	
E.	coli	E21B		 32	 20	 0.0001	 0.0002	 Yes	
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5.4	Heat	stress	is	not	an	effective	way	to	reduce	the	life	span	of	AU37	
	 It	is	known	heat	stress	reduces	life-span	of	the	worms,	hence,	experimental	time,	imitating	the	results	with	non-heat	stress	worms	(Shen	et	al.,	2017).	We	were	interested	to	see	if	we	can	shorten	the	experimental	time	and	obtain	our	results	faster.	In	heat	stress	assay,	the	C.	elegans	incubation	was	held	at	37°C	after	infection.	Heat	stress	assay	shortens	the	time	required	to	perform	an	infection-treatment	experiment,	from	days	to	hours	(Figure	7(A-C)).	However,	we	concluded	that	heat	stress	is	not	an	effective	way	to	reduce	the	experimental	time,	as	we	observed	inconsistent	results	(Table	2).	Variability	in	results	may	be	due	to	counting	error	in	the	liquid	medium,	since	at	37°C	worms	stops	movement	and	becomes	straight,	mimicking	dying	posture	when	still	alive.	In	addition,	the	growth	rate	of	E.	coli	is	faster	at	37°C	compared	to	at	25°C	(Olanya	et	al.,	2014),	thus	it	may	be	a	combination	of	stressed	C.	elegans	and	increased	infection	rate	by	E.	coli	O157:H7.		
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Figure	7	Heat	stress	assay.	The	procedure	for	the	infection-treatment	assay	was	same	as	section	5.3,	except	the	incubation	temperature,	which	was	37°C.	(A)	Life-span	of	infected	(E21B)	and	non-infected	(OP50)	C.	elegans	strain	AU37,	without	ampicillin	treatment.	(B)	Life-span	of	infected	worms	with	16µg/ml	ampicillin	(Amp	16)	and	without	ampicillin	(E21B)	treatment.	(C)	Life-span	of	infected	worms	with	32µg/ml	ampicillin	(Amp	32)	and	without	ampicillin	(E21B)	treatment.
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Table	3	Heat	stress	assay		
	GraphPad	Prism	7	for	Mac	OS	was	used	to	obtain	statistical	summary	on	heat	stress	assay.	Non-infected	worms	(E.	coli	OP50)	and	infected	worms	with	ampicillin	treatment	were	compared	with	infected	worms	(E21B)	to	obtain	the	p-value.	The	p-value	using	Gehan-Breslow-Wilcoxon	test	confirms	significant	difference	between	non-infected	and	treated	worms	compared	to	the	infected	worms	in	experiment	1	but	not	significant	during	experiment	2.	A	p-value	less	than	0.05	is	significant.
Infection	 Ampicillin	Treatment	(µg/ml)	 Median	life-span	T50	(Hours)	
Experiment	1	 Median	life-span	T50	(Hours)	
Experiment	2	P-value	compared	to	E21B	 Significant?	 P-value	compared	to	E21B	 Significant?	Log-rank	(Mantel-Cox)	test	 Gehan-Breslow-Wilcoxon	test	
Log-rank	(Mantel-Cox)	test	 Gehan-Breslow-Wilcoxon	test	
E.	coli	OP50	 0	 4	 0.0131	 0.0008	 Yes	 5	 0.0463	 0.1002	 Yes/	No	
E.	coli	E21B	 0	 1	 NA	 NA	 NA	 3	 NA	 NA	 NA	
E.	coli	E21B	 8	 NA	 NA	 NA	 NA	 3	 0.6473	 0.5072	 No	
E.	coli	E21B	 16	 1	 0.0954	 0.0232	 No/	Yes	 3	 0.9106	 0.9233	 No	
E.	coli	E21B	 32	 1	 0.3133	 0.0254	 No/	Yes	 NA	 NA	 NA	 No	
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5.5	Effect	of	ampicillin	treatment	on	AU37	fed	with	acid	stressed	E.	coli	
O157:H7	cells	The	C.	elegans	assay	could	be	used	to	determine	if	bacterial	pathogens	exposed	to	conditions	found	in	foods	are	more	or	less	suspetable	to	antibiotic	treatment	in-vivo.	An	acid-stressed	experiment	was	performed	because	of	the	concern	that	for	EHEC	infection	the	E.	coli	cells	needs	to	pass	through	our	stomach	acid,	where	they	may	encounter	acid	stress,	in	order	to	colonize	our	gut.	Growth	curve	was	performed	for	E.	coli	O157:H7	grown	in	a	Luria-Bertani	broth	at	pH	6.90	and	pH	5.25	to	determine	the	estimate	time	required	for	the	cells	to	reach	late	exponential	stage	(Figure	8).	To	determine	the	effect	of	acid-stressed	E.	coli	O157:H7	(E21B)	cells	on	C.	
elegans	infection	and	treatment,	we	had	grew	E21B	in	a	Luria-Bertani	broth	with	a	pH	5.25±0.05	(referred	to	as	acid	stressed	cells)	for	12-14	hours	at	37°C	till	the	bacteria	is	in	late	exponential	stage	to	fed	the	L4-stage	worms.	As	a	comparison,	C.	
elegans	AU37	were	infected	with	E21B	grown	in	Luria-Bertani	broth	with	a	pH	of	6.65±0.05	for	6-8	hours	at	37°C.	Control	was	C.	elegans	mutant	AU37	fed	with	E.	coli	OP50	grown	in	Luria-Bertani	broth	with	a	pH	of	6.65±0.05	for	6-8	hours	and	pH	of	5.25±0.05	for	16-18	hours	at	37°C	till	the	cells	reach	to	the	late	exponential	stage.	Further	experimental	procedure	was	run	in	the	same	manner	as	mentioned	in	section	5.3.		Our	results	show	no	significant	difference	between	infected	worms	fed	with	E21B	grown	at	pH	6.65±0.05	and	worms	fed	with	E21B	grown	at	pH	5.25±0.05	
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(Figure	9A).	In	addition,	treatment	with	8µg/ml	and	32µg/ml	ampicillin	concentration	results	in	no	significant	difference	in	the	life-span	of	C.	elegans	mutant	AU37	fed	with	E21B	grown	at	pH	6.65±0.05	compared	to	the	worms	fed	with	E21B	grown	at	pH	5.25±0.05	(Figure	9	(B,	D)).	However,	treatment	with	16µg/ml	ampicillin	concentration	results	in	significantly	shorter	the	life-span	of	C.	elegans	AU37	fed	with	E21B	grown	at	pH	5.25±0.05	compared	to	the	worms	fed	with	E21B	grown	at	pH	6.65±0.05	(p	<	0.05)	(Figure	9C).		Treatment	with	ampicillin	did	not	increase	the	life-span	of	infected	worms	fed	with	E21B	at	either	pH	compared	to	the	infected	worms	without	treatment	(Figure	10	(A-F)).	However,	it	shows	increased	survival	of	the	treated	worms	with	ampicillin	at	the	median	life-span	(T50)	compared	to	the	infected	worms	with	E21B	at	pH	6.65±0.05.	These	results	indicate	that	there	can	be	variablity	in	this	test	system,	since	previously	(Section	5.3),	we	found	the	ampicillin	treatment	increased	the	life-span	of	infected	worms.	Differences	in	this	result	may	be	due	to	higher	initial	infection	per	worm	in	this	experiment	(8.3	x	102	CFU/	worm	compared	to	2.4	x	102	CFU/worm).	Another	possiblity,	may	be	due	to	the	use	of	late	exponential	stage	E.	
coli	O157:H7	cells	in	this	set	of	experiments,	compared	to	the	use	of	stationary	phase	E.	coli	O157:H7	cells	in	section	5.3.	The	last	reason	could	be	due	to	the	age	of	our	stock	C.	elegans	culture	due	to	the	storage	at	15°C.	Despite	not	seeing	a	statistical	increase	in	life-span,	ampicillin	treatment	decreased	the	number	of	bacterial	counts	in	worms	intestine	(Figure	9E).	Figure	9E	shows	the	bacterial	colonization	in	worms	intestine	at	Day	14.	Initial	bacterial	colonization	at	Day	0	in	
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worms	infected	with	E21B	grown	at	pH	6.65±0.05	was	8.3	x	102	CFU/worm	and	in	worms	infected	with	E21B	grown	at	pH	5.25±0.05	was	1.6	x	103	CFU/worm.	At	day	14,	ampicillin	treatment	with	16µg/ml	decreased	the	intestinal	colonization	of	worms	fed	with	E21B	grown	at	pH	5.25±0.05	by	approximately	1.8	log	compared	to	the	1	log	reduction	in	the	worms	fed	with	E21B	grown	at	pH	6.65±0.05,	however	failed	to	increase	the	life-span	of	the	infected	worms.	Further	study	is	needed	to	understand	such	effect	on	the	life-span	of	worms.			
						
Figure	8	E.	coli	O157:H7	growth	curve	at	pH	6.90	vs	at	pH	5.25.	Blue	curve	is	the	growth	of	E.	coli	O157:H7	in	a	Luria-Bertani	broth	pH	6.90	at	37°C.	Red	curve	is	the	growth	of	E.	coli	O157:H7	in	a	Luria-Bertani	broth	pH	5.25	at	37°C.																																		 	
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Figure	9	Effect	of	ampicillin	treatment	on	C.	elegans	AU37	fed	with	E21B	grown	on	pH	6.65	vs.	E21B	grown	on	pH	5.25.	C.	elegans	were	grown	to	L4/	young	adults	and	transferred	to	24	well	plate	containing	»109	CFU	E21B	grown	at	pH	6.65±0.05	and	
»109	CFU	E21B	grown	at	pH	5.25±0.05	per	1ml	M9	buffer	(v/v).	Worms	were	fed	with	E21B	for	24	hours	in	an	M9	buffer.	Worms	were	transferred	to	96	transwell	plate	and	fed	with	live	E.	coli	OP50	and	ampicillin	(0µg/ml,	8µg/ml,	16µg/ml,	and	32µg/ml).	GraphPad	Prism	7	was	used	for	statistical	analysis.	(A)	Life-span	of	infected	worms	without	ampicillin	treatment.	(B)	Life-span	of	infected	worms	with	8µg/ml	ampicillin	treatment.	(C)	Life-span	of	infected	worms	with	16µg/ml	ampicillin	treatment.	(D)	Life-span	of	infected	worms	with	32µg/ml	ampicillin	treatment.	(E)	Intestinal	colonization	of	infected	worms	at	Day	14	with	and	without	ampicillin	treatments	(E21B,	Amp	8,	Amp	16,	Amp	32),	the	dotted	line	indicates	minimum	detectable	level	(1	x	101	CFU/worm).	
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Figure	10	Effect	of	ampicillin	treatment	on	C.	elegans	AU37	fed	with	E21B	grown	on	pH	6.65	and	E21B	grown	on	pH	5.25.	C.	elegans	were	grown	to	L4/	young	adults	and	transferred	to	24	well	plate	containing	109	CFU	E21B	grown	at	pH	6.65	and	109	CFU	E21B	grown	at	pH	5.25	per	1ml	M9	buffer	(v/v).	Worms	were	fed	with	E21B	for	24	hours	in	an	M9	buffer.	Worms	were	transferred	to	96	transwell	plate	and	fed	with	live	E.	coli	OP50	and	ampicillin	(0µg/ml,	8µg/ml,	16µg/ml,	and	32µg/ml).	GraphPad	Prism	7	was	used	for	statistical	analysis.	(A)	Life-span	of	infected	worms	fed	with	E21B	grown	at	pH	6.65	(Infected	pH	6.65)	and	treated	with	8µg/ml	ampicillin	(Amp	8	pH	6.65).	(B)	Life-span	of	infected	worms	fed	with	E21B	grown	at	pH	6.65	(Infected	pH	6.65)	and	treated	with	16µg/ml	ampicillin	(Amp	16	pH	6.65).	(C)	Life-span	of	infected	worms	fed	with	E21B	grown	at	pH	6.65	(Infected	pH	6.65)	and	treated	with	32µg/ml	ampicillin	(Amp	32	pH	6.65).	(D)	Life-span	of	infected	worms	fed	with	E21B	grown	at	pH	5.25	(Infected	pH	5.25)	and	treated	with	8µg/ml	ampicillin	(Amp	8	pH	5.25).	(E)	Life-span	of	infected	worms	fed	with	E21B	grown	at	pH	5.25	(Infected	pH	5.25)	and	treated	with	16µg/ml	ampicillin	(Amp	16	pH	5.25).	(F)	Life-span	of	infected	worms	fed	with	E21B	grown	at	pH	5.25	(Infected	pH	5.25)	and	treated	with	32µg/ml	ampicillin	(Amp	32	pH	5.25).	
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CHAPTER	6	
CONCLUSIONS	
	In	conclusion,	C.	elegans	needs	live	E.	coli	OP50	to	get	enough	nutrients	to	grow	and	survive.	C.	elegans	strain	AU37	is	more	suitable	compared	to	N2	strain	for	the	E.	coli	O157:H7	infection-treatment	assay,	as	AU37	is	more	susceptible	to	bacterial	infection	compared	to	wild-type	N2	strain.		Our	results	indicate	that	C.	elegans	is	an	appropriate	model	to	use	as	an	in-
vivo	study	for	EHEC	infection	and	treatment	as	E.	coli	O157:H7	colonize	the	worm’s	intestine	and	the	treatment	with	ampicillin	concentration	8µg/ml,	16µg/ml,	and	32µg/ml	significantly	increases	the	life-span	of	the	worms	compared	to	the	infected	worms	without	ampicillin	treatment.		In	contrast,	when	ampicillin	treatment	was	used	on	acid-stressed	and	non-acid-stressed	late	exponential	stage	E.	coli	O157:H7	cells,	it	failed	to	increase	the	life-span	of	the	worms	infected	with	acid-stressed	and	non-acid	stressed	E.	coli	O157:H7	cells.	This	may	possibly	be	due	to	the	use	of	late	exponential	stage	E.	coli	O157:H7	cells	compared	to	the	use	of	stationary	phase	E.	coli	O157:H7	cells	in	the	previous	experiment.	In	addition,	ampicillin	treatment	with	concentration	16µg/ml	on	C.	elegans	infected	with	acid-stressed	E.	coli	O157:H7	cells	significantly	reduces	the	life-span	of	the	worms	compared	to	the	ampicillin	treated	(16µg/ml)	non-acid	stressed	E.	coli	O157:H7	cells,	even	though	ampicillin	reduces	the	intestinal	bacterial	colonization	to	approximately	1.8	log	compared	to	approximately	1	log	for	non-acid	
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stressed	E.	coli	O157:H7.	Hence,	further	studies	need	to	perform	to	understand	such	effect	on	the	life-span	of	the	worms.		 	
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APPENDIX	
EXPANDED	LAB	PROCEDURES	
E.	COLI	O157:H7	INFECTION-TREATMENT	IN	C.	ELEGANS	PROCEDURE	
	
1. Preparation	of	nematode	growth	media	(NGM)	plate	and	concentrated	
E.	coli	OP50	
• Prepare	NGM	plate	and	concentrated	E.	coli	OP50	a	week	before	the	start	of	the	experiment.		
A. NGM	plate	seeded	with	OP50	preparation	
o Prepare	NGM	plate	using	NGM	growth	media	and	follow	the	manufacture	instructions.		
o Grow	E.	coli	OP50	in	a	Luria-Bertani	broth	for	12-14	hours	at	37°C	and	pipet	1ml	onto	each	of	the	2	days	old	NGM	plate.	Let	the	plate	sit	at	the	room	temperature	for	another	two	days.	This	is	referred	to	as	OP50	seeded	NGM	plates.	Store	the	plates	at	4°C	till	ready	to	use.	
B. Concentrated	E.	coli	OP50	
o Grow	E.	coli	OP50	in	a	Luria-Bertani	broth	for	12-14	hours	at	37°C	and	centrifuge	using	a	50ml	centrifuge	tube,	collect	the	pellet	and	discard	the	supernatant	
o Weigh	the	pellet	and	prepare	100	mg/ml	OP50	concentration	using	sterile	water.	This	is	referred	to	as	concentrated	OP50	for	C.	elegans	food	in	96	transwell	plate.		
2. C.	elegans	stock	culture	preparation	
• Chunk	a	piece	of	agar	containing	many	AU37	worms	received	from	CGC	or	from	your	old	NGM	plate	containing	AU37	worms	and	place	it	onto	your	freshly	prepared	NGM	agar	seeded	with	OP50.	Incubate	the	plate	at	15°C.	Plate	can	be	stored	at	15°C	for	up	to	4	months	and	can	be	used	when	needed.			
3. Infection-Treatment	life-span	assay	using	C.	elegans	strain	AU37	
	
Day	1:	Chunk	a	piece	of	NGM	agar	
• Chunk	a	piece	of	agar	containing	many	AU37	worms	and	transfer	it	onto	three	new	NGM	plates	seeded	with	OP50.	Incubate	the	plates	at	15°C	for	approximately	4	days	for	the	worms	to	lay	eggs.		
Day	5:	Collect	the	eggs	(synchronization	of	worms)		
• Wash	each	of	the	NGM	plates	having	many	eggs	with	approximately	3	ml	sterile	water	for	couple	of	time.	Dispense	the	washed	liquid	containing	worms	into	15ml	centrifuge	tube.	
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• Centrifuge	at	2000g	for	2mins.	Discard	the	supernatant.		
• Prepare	10ml	bleach	solution	(1ml	10M	NaOH,	1.8ml	household	bleach,	and	7.2ml	sterile	water)	into	a	15ml	centrifuge	tube	(You	can	prepare	5ml	or	10ml	bleach	depends	on	the	density	of	worms	you	have).	
• Add	the	bleach	solution	to	the	washed	worms	tube,	and	vortex	at	high	speed	for	2mins.	Centrifuge	at	2000g	for	1min	and	discard	the	supernatant.	Add	approximately	10ml	M9	buffer	to	neutralize	the	bleach	effect	and	vortex	little	(All	this	process	in	this	step	should	be	really	fast,	should	not	exceed	>3.5	mins,	or	the	eggs	won’t	hatch	out	the	next	day),	and	then	centrifuge	at	2000g	for	2mins,	and	discard	the	supernatant.	At	this	stage	you	should	have	only	eggs	in	your	tube	(may	contains	few	dead	worms).	
• Add	10ml	M9	buffer	one	more	time	and	centrifuge	at	2000g	for	another	2mins,	discard	the	supernatant,	and	add	1ml	of	M9	buffer.	
• Incubate	the	centrifuge	tube	containing	eggs	horizontally	at	25°C	for	24	hours	for	the	eggs	to	hatch	out.	After	24	hours	the	worms	should	be	in	L1	stage.		
Day	6:	Transfer	of	L1	stage	worms	and	E21B	streak	plate	A. Transfer	the	L1	stage	worms	using	a	pipet	onto	NGM	plate	seeded	with	OP50	and	incubate	the	plate	at	25°C	for	45-50	hours.	Worms	should	be	at	L4-young	adult	stage	after	45-50	hours.	B. Streak	a	new	Tryptic	Soy	Agar	(TSA)	plate	from	a	frozen	E21B	stock	and	incubate	at	37°C	for	18-20	hours.	Follow	the	same	procedure	with	OP50.		
Day	7:	E21B	and	OP50	culture	preparation	
• Transfer	3	colonies	from	streaked	E21B	from	Day	6	into	two	10ml	Luria-Bertani	broth.	Incubate	the	tubes	at	37°C	for	18-20	hours	on	a	125rpm	shaker.	Follow	the	same	procedure	with	OP50.		
Day	8:	Infecting	worms	with	E21B		
A. Preparation	of	E21B	and	OP50	culture		
• Take	out	E21B	and	OP50	culture	tubes	from	Day	7,	dilute	the	culture	10x,	and	read	the	absorbance	at	wavelength	625nm	using	spectrophotometer.	Absorbance	of	0.08	–	0.1	at	wavelength	625nm	is	consider	having	approximately	108	CFU/ml	bacteria.	
• Centrifuge	the	original	9	ml	E21B	and	OP50	culture	containing	approximately	109	CFU/ml	bacteria	at	2500g	for	10	minutes	and	discard	the	supernatant.		
• Add	0.9	ml	M9	buffer	to	each	tube	to	make	the	final	bacterial	concentration	of	1010	CFU/ml.		
B. Preparation	of	worms		
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• Pipet	approximately	2-3ml	M9	buffer	into	each	of	the	Day	6	plates	containing	synchronized	L4-young	adult	stage	AU37	worms	and	collect	it	into	a	15ml	centrifuge	tube.	Centrifuge	the	worms	at	2000g	for	1min	with	M9	buffer	three	times	to	remove	any	OP50	residue.	Discard	the	supernatant	using	pipet.		
• Add	1ml	of	M9	buffer	and	transfer	the	mixture	into	2ml	micro	centrifuge	tube.	
• Pipet	five	10	µl	drops	on	a	sterile	petri	dish	and	count	the	number	of	worms.	Average	the	worms	per	10	µl	and	record	the	number.		
C. Infection	in	24	well	plate	
• Add	approximately	100	worms	into	24	well	plate	and	make	the	final	volume	to	900	µl	using	M9	buffer.	
• Add	100	µl	E21B	to	make	the	final	E21B	concentration	of	109	CFU/ml.	Run	control	on	side	by	adding	100	µl	OP50	to	make	the	final	OP50	concentration	of	109	CFU/ml.	
• Incubate	the	plate	at	25°C	for	24	hours.		
Day	9:	Treatment	with	ampicillin		
A. Preparation	of	bacterial	food	with	varied	ampicillin	concentration	
• Add	concentrated	OP50	to	the	final	concentration	of	3mg/ml	and	ampicillin	to	the	final	desired	concentration	using	M9	buffer	in	a	sterile	tube.	Mix	the	mixture	well	for	1min	using	vortex	at	high	speed.	
• Add	250	µl	of	the	food	mixture	to	the	bottom	of	96	transwell	plate.	
	
B. Preparing	and	adding	worms	to	use	in	96	transwell	plate	
• Transfer	infected	worms	(E21B)	from	Day	8	into	15ml	centrifuge	tube.	Follow	same	procedure	for	control	(OP50)	worms.	
• Centrifuge	the	worms	at	2000g	for	1	minute	and	discard	the	supernatant.	Add	M9	buffer	and	repeat	the	procedure	five	times	to	remove	most	residue	of	E21B	and	OP50.		
• Pipet	five	10µl	drops	of	each	of	the	infected	and	control	worms	into	a	sterile	petri	dish	to	determine	the	number	of	worms	per	10µl.	Average	and	record	the	number.	
• Transfer	approximately	10	infected	worms	into	a	micro	centrifuge	tube	to	determine	the	bacterial	colonization	in	worms’	intestine.	
• Transfer	approximately	10	worms	into	each	of	the	insert	well	in	transwell	plate	containing	food	in	the	bottom	wells.		
• Incubate	the	plate	at	25°C	and	record	the	number	of	viable	worms	every	day	to	every	other	day.	
	
C. Bacterial	colonization	in	the	worms	
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• Add	1mM	sodium	azide	to	the	final	volume	of	250µl	into	approximately	10	infected	worms	tube.	
• Centrifuge	the	worms	at	2000g	for	1min	and	discard	the	supernatant	using	pipet.	Add	1mM	sodium	azide	to	the	final	volume	of	250µl	and	repeat	the	step	3	times.		
• Add	50µl	of	supernatant	to	the	Sorbitol	MacConkey	Agar	to	determine	the	external	bacterial	count.		
• Add	approximately	400mg	of	1mm	silicon	carbide	particles	into	the	tube	containing	10	infected	worms	and	vortex	at	high	speed	for	1min	to	disrupt	the	worms.	
• Perform	serial	dilution	and	plate	onto	Sorbitol	MacConkey	Agar	to	determine	total	bacterial	count	(Internal	+	External)	per	10	worms.	
• Incubate	the	plates	at	37°C	for	18-20	hours.		 	
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